🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Implementation of Anal Cancer Screening and Treatment in Nigeria

RecruitingNAAges any - anyAllUniversity of Maryland, Baltimore
NCT05817370 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is a feasibility pilot trial testing 2 types of training protocols on a single physician. The first training protocol is the current standard and was developed in high-income settings. The second training protocol will be developed so tailored to the Nigerian setting. Investigators will test if the physician performs differently in their ability to conduct anal cancer screening and treatment between the 2 training protocols.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Possess a medical degree in medical sciences (MBBS or equivalent) 2. At least 2-5 years of experience working with clinical HIV/AIDS community 3. Must be registered with the medical and dental council of Nigeria 4. Possess a current medical practicing license 5. Willing to work with the Sexual Gender Minority Community Exclusion Criteria:
💊

What it tests

  • Enhanced Training on screening and treatment of HSIL (e-STH)
📍

Where

1 site
International Center for Advocacy on Right to Health (ICARH)
Abuja, Nigeria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy